Screener
United Therapeutics UTHR Other Liabilities Noncurrent
Other Liabilities Noncurrent at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's other liabilities noncurrent?
- United Therapeutics (UTHR) reported other liabilities noncurrent of $212M in Q2 2026.
- How has United Therapeutics's other liabilities noncurrent changed year-over-year?
- United Therapeutics's other liabilities noncurrent increased by 2.3% year-over-year, from $207.3M to $212M.
- What is the long-term trend for United Therapeutics's other liabilities noncurrent?
- Over 5 years (2020 to 2025), United Therapeutics's other liabilities noncurrent has grown at a 18.3% compound annual growth rate (CAGR), from $96.5M to $223.2M.
- What does other liabilities noncurrent mean?
- Other Liabilities Noncurrent as reported by United Therapeutics Corp.
Ask your AI about United Therapeutics's other liabilities noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude